Women's Health

|2 min read

TLDR; Our Top Stories of 2025

From regulatory shifts to breakthrough diagnostics, the stories that defined clinical labs in 2025
|3 min read

FDA Clears Roche HER2 Tests to Expand Treatment Options in Metastatic Breast Cancer

Roche’s PATHWAY HER2 (4B5) test is the only test approved to identify all levels of HER2 expression
|2 min read

Scientists Uncover New Driver of Ovarian Cancer Spread

Newly identified F2R receptor shows promise for earlier detection and improved treatment outcomes
|1 min read

Advancing Syphilis Detection Through Rapid Testing

Learn how rapid testing initiatives are addressing diagnostic delays in pregnancy and supporting earlier intervention against congenital syphilis
Sponsored by
|3 min read

Biomarker Can Help Predict Preeclampsia Risk in Women with Sickle Cell Disease

Findings pave way for more effective pregnancy management in higher risk patient population
|2 min read

Missing First Screening Appointment Linked to Higher Risk of Breast Cancer Death

Targeted measures needed to boost attendance among initial non-attenders and reduce mortality risk, say researchers
|2 min read

Excessive Folic Acid Intake in Pregnancy Linked to Gestational Diabetes

With pregnancy supplement use at an all-time high, researchers say it’s time to revisit guidelines
|2 min read

Mayo Clinic Study Reveals Hidden Causes of Heart Attacks in Younger Adults, Especially Women

Study highlights overlooked heart attack causes in adults under 65, challenging long-held beliefs and revealing risks of misdiagnosis
|4 min read

First Global Guidelines for Pregnancy and Inflammatory Bowel Disease Developed

UCSF's Uma Mahadevan, MD, leads international consensus conference, with goal of improving treatment and outcomes for women with IBD and their children
|2 min read

One Step Closer to Improving ER+ Breast Cancer Patients’ Response to Therapy

The findings support further clinical studies to determine whether this marker may help identify patients who could benefit from CDK4/6 inhibitors
|2 min read

Why Breast Cancer Therapy Tamoxifen May Lead to Higher Risk of Uterine Cancer

Study shows how tamoxifen may raise uterine cancer risk and points to a possible way to prevent it
|2 min read

AI Outperforms Traditional Biomarkers in Predicting Breast Cancer Immunotherapy Success

New study in Nature Communications highlights AI's role in transforming immunotherapy decisions and precision oncology
Page 1 of 10